Birch Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Birch Capital Management's AMGN Position: Q3 2026 in Review
Birch Capital Management reduced its Amgen (AMGN) stake by 0.82% in Q3 2026, selling an estimated $84.1K and leaving 25,374 shares worth $10.7M. The position accounts for 5.02% of the portfolio, ranked #4.
Birch Capital Management first reported a position in AMGN in Q4 2019 and has held it in 28 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Birch Capital Management held 25,374 shares of Amgen worth $10.7M as of Q3 2026.
- Birch Capital Management sold 211 Amgen shares in Q3 2026, an estimated $84.1K.
- Amgen made up 5.02% of Birch Capital Management's portfolio in Q3 2026, its #4 holding.
- Birch Capital Management first reported a position in Amgen in Q4 2019 and has held it in 28 quarters since.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Birch Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.